Trial Profile
Markers of hypercoagulability and risk of death and rehospitalisation in heart failure patients: a pilot study on the effects of Fondaparinux
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 02 Jul 2014
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 02 Jul 2014 New trial record